CO2 (carbon dioxide) laser vaporisation
ProcedureCO2 (carbon dioxide) laser is used to vaporise the inner wall of the endometrioma
NCT Number: NCT03826355
Endometriosis is a disease characterized by the presence of endometrial tissue outside the uterus cavity, causing important chronic pain and sterility in those patients suffering from it. It affects from 10 to 20% of women at reproductive age. Different types of endometriosis, which can coexist in the same patient, exist: deep infiltrating endometriosis (implants infiltrate > 5 mm the peritoneum), superficial endometriosis and ovarian endometriosis (OMA). OMA sometimes require surgery, and it is known that healthy ovarian tissue is also injured during resection. Consequently, ovarian reserve decreases, worsening the reproductive prognosis of patients affected. The main objective of the present study is to compare laser versus conventional OMA excision according to ovarian reserve in a pairwise-data study.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CO2 (carbon dioxide) laser is used to vaporise the inner wall of the endometrioma
Identification of a cleavage plane and perform the cystectomy removing all the wall of the endometrioma from the healthy ovarian tissue
Time frame: 7 months
Antral follicular count by ultrasound: number of antral follicles.
Time frame: 7 months
Ovarian volume will be assesses by ultrasound, units given with milliliters
Time frame: 6 months after surgery
Pregnancy rate will be recorded during the 6 months follow-up
Hospital Clinic of Barcelona
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06145438
Endometriosis Ovary
Semarang, Central Java, Indonesia
View Trial DetailsNCT06207448
Endometriosis Ovary
Strasbourg, France
View Trial DetailsNCT04461899
Endometriosis, Endometriosis Ovary
Bron, France
View Trial DetailsNCT05272930
Dienogest, Endometriosis Ovary
Istanbul, Turkey (Türkiye)
View Trial Details